Fibrillin 1 Antibody (FBN1/6933) [DyLight 488]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-21016G
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA, Immunohistochemistry-Paraffin
Label
DyLight 488 (Excitation = 493 nm, Emission = 518 nm)
Antibody Source
Monoclonal Mouse IgG1 kappa Clone # FBN1/6933
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Recombinant human Fibrillin 1 fragment around aa 330-476 (Exact sequence is proprietary)
Localization
Extracellular matrix.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Applications for Fibrillin 1 Antibody (FBN1/6933) [DyLight 488]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Fibrillin-1/FBN1
Long Name
Fibrillin-1
Alternate Names
ACMICD, Asprosin, Fibrillin 1, GPHYSD2, SSKS, WMS2
Gene Symbol
FBN1
Additional Fibrillin-1/FBN1 Products
Product Documents for Fibrillin 1 Antibody (FBN1/6933) [DyLight 488]
Product Specific Notices for Fibrillin 1 Antibody (FBN1/6933) [DyLight 488]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...